BiomX (PHGE) Accumulated Expenses (2021 - 2025)
BiomX (PHGE) posted Accumulated Expenses of $720000.0 for Q4 2025, down 5.51% sequentially from $762000.0 in Q1 2025, and down 15.69% YoY from $854000.0 in Q4 2024.
BiomX (PHGE) Accumulated Expenses (2021 - 2025) Analysis & Trends
BiomX has reported Accumulated Expenses for 5 years, with the latest figure at $720000.0 in Q4 2025.
- Quarterly Accumulated Expenses fell 15.69% year-over-year to $720000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $720000.0 (down 15.69% YoY) and the FY2025 annual result came in at $720000.0, down 15.69% from the prior year.
- Accumulated Expenses eased to $720000.0 in Q4 2025 per PHGE's latest filing, from $762000.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $5.5 million in Q4 2021 and troughed at $720000.0 in Q4 2025.
- A 5-year average of $2.3 million and a median of $1.7 million in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses slumped 83.73% in 2022, then soared 45.32% in 2023.
- Over 5 years, Accumulated Expenses stood at $5.5 million in 2021, then plunged by 83.73% to $887000.0 in 2022, then soared by 45.32% to $1.3 million in 2023, then sank by 33.75% to $854000.0 in 2024, then declined by 15.69% to $720000.0 in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $720000.0, $762000.0, and $854000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BiomX | 351,774.34 | -816,225.66 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 720,000.00 |
| Mar 31, 2025 | 762,000.00 |
| Dec 31, 2024 | 854,000.00 |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Mar 31, 2023 | 2.96 Mn |
| Dec 31, 2022 | 887,000.00 |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 5.25 Mn |
| Dec 31, 2021 | 5.45 Mn |